Epstein-Barr virus infection and its role in the expanding spectrum of human diseases

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 1, 1998, Pages 11-18

  Okano, M ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus; Human diseases

Indexed keywords

ANTIBODY RESPONSE; EPSTEIN BARR VIRUS; HUMAN; IMMUNE RESPONSE; LABORATORY TEST; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; VIRUS DETECTION; VIRUS GENOME; VIRUS INDUCTION; VIRUS INFECTION;

ANIMALS; BURKITT LYMPHOMA; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; INFECTIOUS MONONUCLEOSIS; MALE; MICE; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; STOMACH NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 0031884439     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035259850157796     Document Type: Review

References (60)

1. Liebowitz D, Kieff E. Epstein-Barr virus. In: Roizman B, Whilley RJ, Lopez C, editors. The human herpesvirus. New York: Raven Press 1993: 107-72
2. Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev 1988; 1: 300-12
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9
4. Kanegane H, Kanegane C, Yachie A, Miyawaki T, Tosato G. Infectious mononucleosis as a disease of early childhood in Japan caused by primary Epstein-Barr virus infection. Acta Paediatr Jpn 1997; 39: 166-71
5. Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989; 84: 51-5
6. Revoltella PP, Vigneti E, Fruscalzo A, Park M, Ragona G, Rocchi G, et al. Epstein-Barr virus DNA sequences in precursor monocyte-macrophage cell lines established from bone marrow of children with maturation defect of hematopoiesis. J Gen Virol 1989; 70: 1203-5
7. McClain K, Leach CT, Jenson HB, Joshi VV, Pollock BH, Palmley RT, et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 1995; 332: 12-8
8. Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, et al. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995; 332: 19-25
9. Jones K, Rivera C, Sgadari C, Franklin J, Max EE, Bhatia K, Tosato G. Infection of human endothelial cells with Epstein-Barr virus. J Exp Med 1995; 182: 1213-21
10. Okuno M, Purtilo DT. Interferons and Epstein-Barr virus infection. In: Jaffe HS, Bucalo LR, Sherwin SA, editors. Anti-infective applications of interferon-gamma. New York: Marcel Dekker Inc. 1992: 213-25
11. Okano M, Purtilo DT. Simple assay for evaluation of Epstein-Barr virus-specific cytotoxic T lymphocytes. J Immunol Meth 1995; 184: 149-52
12. Tamaki H, Beaulieu BL, Somasundaran M, Sullivan JL. Major histocompatibilily complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children. J Infect Dis 1995; 172: 739-46
13. Rowe M, Lear AL, Croom-Carter D, Davis AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA-1 positive latency in B lymphocytes. Virology 1992; 66: 122-31
14. Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, et al. Heterogeneous expressions of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 1995; 86: 659-65
15. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, et al. Inhibition of antigen processing by the internal repeal region of the Epstein-Barr virus nuclear antigen-1. Nature 1995; 375: 685-8
16. Pea D, Fourcadec C, Leblond V, Rowe M, Joab I, Edelman L, et al. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Transplantation 1994; 58: 317-24
17. Brousset P, Schlaifer D, Meggetto F, Bachmann E, Rothenberger S, Pris J, et al. Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease. Blood 1994; 84: 2447-51
18. Knecht H, Joske DJL, Emery-Goodman A, Bachmann E, Bachmann F, Odermatt BF, et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937-42
19. Sandvej K, Peh S-C, Andresen BS, Pallesen G. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Denish peripheral T-cell lymphomas. Blood 1994; 84: 4053-60
20. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signalling proteins for the tumor necrosis factor receptor family. Cell 1995; 80: 389-99
21. Huen DS, Henderson SA, Croom-Carter D, Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP-1) mediate activation of NF-kB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995; 10: 549-60
22. Smir BN, Hauke RJ, Bierman PJ, Gross TG, d'Amore F, Anderson JR, et al. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorder. Lab Invest 1996; 75: 575-88
23. Linde A. Diagnosis of Epstein-Barr virus-related diseases. Scand J Infect Dis 1996; 28 Suppl 100: 83-8
24. Okano M, Bashir RM, Davis JR, Purtilo DT. Detection of primary Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease receiving immunoglobulin prophylaxis. Am J Hematol 1991; 36: 294-6
25. Wrightham MN, Stewart JP, Janjua NJ, Pepper SDV, Sample C, Rooney CM, et al. Antigenic and sequence variation in the C-terminal unique domein of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 1995; 208: 521-30
26. Young L, Alfieri C, Hennessy K, Evans H, O'Hare C, Anderson K, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues from patients with EBV lymphoproliferative disease. N Engl J Med 1989; 321: 1080-5
27. Okano M, Davis JR, Thiele GM. Full presence of Epstein-Barr virus (EBV)-encoded latent proteins in tissues from a patient with severe chronic active EBV infection syndrome. Acta Haematol 1997; 97: 242-3
28. Gratama JW, Oosterveer MAP, Klein G, Ernberg I. EBNA size polymorphism can be used to trace Epstein-Barr virus spread with families. J Virol 1990; 64: 4703-8
29. Gan Y-J, Sullivan JL, Sixbey JW. Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J Infect Dis 1994; 170: 436-9
30. Cinque P, Brytting M, Vago L, Costagna A, Parravicini C, Zanchetta N, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993; 342: 398-401
31. Imai S, Usui N, Sugiura M, Osato T, Sato T, Tsutsumi H, et al. Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections. J Med Virol 1993; 40: 278-84
32. Weiss LM, Chen YY, Lin XF, Shibata D. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139: 1259-65
33. Razzouk B, Srinivas S, Sample CE, Singh V, Sixbey JW. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis 1996; 173: 529-35
34. Okano M, Kikuta H, Abo W, Koizumi S, Aya T, Yano S, et al. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma. Jpn J Clin Oncol 1992; 22: 320-4
35. Sixbey JW, Tao QY. Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 1992; 255: 1578-80
36. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr-virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992; 7: 2131-40
37. Chang Y-S, Su I-J, Chung P-J, Shu C-H, Ng C-K, Wu S-J, et al. Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer 1995; 62: 673-7
38. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995; 333: 693-8
39. Filipovich AH, Mathur A, Kamat D, Kersey JH, Shapiro RS. Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency 1994; 5: 91-112
40. Okano M, Nakanishi M, Taguchi Y, Sakiyama Y, Matsumoto S. Primary immunodeficiency diseases and Epstein-Barr virus-induced lymphoproliferative disorders. Acta Paediatr Jpn 1992; 34: 385-92
41. Okano M, Sakiyama Y, Matsumoto S, Mizuno F, Osato T, Noro S, et al. A serological study of Epstein-Barr virus infection in Japanese patients with ataxia telangiectasia. Immunol Infect Dis 1994; 4: 65-8
42. Okano M, Mizuno F, Hirano T, Koyanagi T, Noro S, Sakurada N, et al. Serologically activated Epstein-Barr virus infection in Japanese recipients with renal allografts. Immunol Infect Dis 1993; 3: 263-5
43. Greenspan JS, Greenspan D, Lennette ET. Replication of Epstein-Barr virus within epithelial cells of hairy oral leukoplakia an AIDS associated lesion. N Engl J Med 1986; 313: 1564-70
44. Seemayer TA, Gross TG, Egeler RM, Pirruccello SJ, Davis JR, Kelly CM, et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995; 38: 471-8
45. Okano M, Thiele GM, Gross TG, Davis JR, Purtilo DT. Differential cellular susceptibility to Epstein-Barr virus in a patient with X-linked lymphoproliferative disease. J Med Virol 1990; 32: 47-52
46. Hunt BJ, Thomas JA, Burke M, Walker H, Yacoub M, Crawford DH. Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient. Transplantation 1996; 62: 869-72
47. Egeler RM, Kraker J, Slater R, Purtilo DT. Documentation of Burkitt lymphoma with t(8;14) (q24;q32) in X-linked lymphoproliferative disease. Cancer 1992; 70: 683-7
48. Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT. Severe chronic active Epstein-Barr virus infection syndrome. CHn Microbiol Rev 1991; 4: 129-35
49. Okano M, Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 1996; 53: 111-5
50. Su IJ, Hsieh HC, Lin KH, Wen WC, Kao CL, Chen CJ, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathological and molecular genetic study. Blood 1991; 77: 799-808
51. Ott G, Ott MM, Feller AC, Seidl S, Muller-Hermelink HK. Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population. Int J Cancer 1992; 51: 562-7
52. Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Amer J Pathol 1992; 140: 769-74
53. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994; 91: 9131-5
54. Rowlands DC, Ito M, Mangham DC, Reynolds G, Herbst H, Hallissey MT, Fielding JWL, Newbold KM, Jones EL, Young LS, Niedobitek G. Epstein-Barr virus and carcinomas: rare association of the virus with gastric carcinoma. Br J Cancer 1993; 68: 1014-9
55. Okano M. Therapeutic approaches for severe Epstein-Barr virus infection. Pediatr Hematol Oncol 1997; 14: 109-19
56. Anderson J. Clinical and immunological considerations in Epstein-Barr virus-associated diseases. Scand J Infect Dis 1996; 28 Suppl 100: 72-82
57. Matsukawa Y, Okano M, Ishikawa N, Imai S. Severe thrombocytopenic purpura associated with primary Epstein-Barr virus infection. J Infect 1994; 29: 107-9
58. Okano M, Sakiyama Y, Matsumoto S, Mizuno F, Osato T. High irradiation sensitivity of Epstein-Barr virus (EBV) in lymphoblastoid cells from patients with ataxia telangiectasia and EBV genome-positive Burkitt's lymphoma. Int J Oncol 1993; 2: 1023-6
59. Okano M, Taguchi Y, Nakamine H, Pirruccello SJ, Davis JR, Beisel KW, et al. Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice. Am J Pathol 1990; 137: 517-22
60. Murphy WJ, Funakoshi S, Beckwith M, Rushing M, Rushing SE, Conley DK, Armitage RJ, et al. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes. Blood 1995; 86: 1946-53